Related Experiment Videos
Neonatal thyroid screening as a monitoring tool for the control of iodine deficiency
1ICCIDD, Brussels, Belgium. fdelange@ulb.ac.be
Insights
Iodine deficiency elevates neonatal thyroid-stimulating hormone (TSH), a key indicator of potential brain damage. Neonatal screening for TSH effectively monitors iodine status in populations.
Area of Science:
- Endocrinology
- Public Health
- Neonatal Medicine
Background:
- Iodine deficiency is a global health concern impacting brain development.
- Elevated neonatal thyroid-stimulating hormone (TSH) is a primary indicator of insufficient thyroid hormone supply.
- Brain damage is the most significant complication of iodine deficiency in newborns.
Purpose of the Study:
- To review studies on neonatal thyroid function in iodine deficiency.
- To confirm the utility of neonatal TSH screening for assessing iodine status.
- To establish TSH frequency thresholds for classifying iodine deficiency severity.
Main Methods:
- Review of existing scientific literature on neonatal thyroid function and iodine deficiency.
- Analysis of neonatal thyroid-stimulating hormone (TSH) levels in various iodine supply conditions.
- Comparison of TSH frequency distributions against established WHO/UNICEF/ICCIDD criteria.
Main Results:
- A TSH frequency above 5 mU/L blood below 3% signifies adequate iodine supply.
- Frequencies of 3-19.9%, 20-39.9%, and over 40% indicate mild, moderate, and severe iodine deficiency, respectively.
- Neonatal thyroid screening is a sensitive tool for population-level iodine status monitoring.
Conclusions:
- Neonatal TSH levels are a reliable indicator of iodine deficiency and potential neurodevelopmental risks.
- Population-level TSH screening provides crucial data for public health interventions.
- Maintaining adequate iodine supply is critical for preventing neonatal brain damage.
Abstract:
In conditions of iodine deficiency, the frequency distribution of neonatal thyroid-stimulating hormone (TSH) is shifted towards elevated values. Elevated serum TSH in the neonate indicates insufficient supply of thyroid hormones to the developing brain, and therefore constitutes the only indicator that allows prediction of brain damage, which is the main complication of iodine deficiency. This paper reviews studies on neonatal thyroid function in iodine deficiency and confirms the former statement by WHO/UNICEF/ICCIDD that the frequency of neonatal TSH above 5 mU/L blood is below 3% in conditions of normal iodine supply, that a frequency of 3-19.9% indicates mild iodine deficiency and that frequencies of 20-39.9% and above 40% indicate moderate to severe iodine deficiency, respectively. Neonatal thyroid screening appears as a particularly sensitive index in the monitoring of iodine supply at a population level.